Compare Pfizer with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ASTRAZENECA PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ASTRAZENECA PHARMA PFIZER/
ASTRAZENECA PHARMA
 
P/E (TTM) x 42.6 113.1 37.7% View Chart
P/BV x 7.1 34.6 20.4% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 PFIZER   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
ASTRAZENECA PHARMA
Mar-18
PFIZER/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,8401,278 300.5%   
Low Rs2,080883 235.7%   
Sales per share (Unadj.) Rs455.0228.4 199.2%  
Earnings per share (Unadj.) Rs93.810.4 904.9%  
Cash flow per share (Unadj.) Rs109.416.3 672.7%  
Dividends per share (Unadj.) Rs22.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs658.298.8 666.4%  
Shares outstanding (eoy) m45.7525.00 183.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.7 137.5%   
Avg P/E ratio x31.6104.2 30.3%  
P/CF ratio (eoy) x27.166.4 40.7%  
Price / Book Value ratio x4.510.9 41.1%  
Dividend payout %24.00-   
Avg Mkt Cap Rs m135,42027,008 501.4%   
No. of employees `0002.61.4 194.0%   
Total wages/salary Rs m3,2381,535 210.9%   
Avg. sales/employee Rs Th7,911.44,210.9 187.9%   
Avg. wages/employee Rs Th1,230.91,132.2 108.7%   
Avg. net profit/employee Rs Th1,630.7191.1 853.5%   
INCOME DATA
Net Sales Rs m20,8155,710 364.5%  
Other income Rs m1,674123 1,366.4%   
Total revenues Rs m22,4895,833 385.6%   
Gross profit Rs m5,712463 1,234.0%  
Depreciation Rs m714147 484.3%   
Interest Rs m730-   
Profit before tax Rs m6,599438 1,506.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309179 1,290.4%   
Profit after tax Rs m4,291259 1,655.9%  
Gross profit margin %27.48.1 338.5%  
Effective tax rate %35.040.8 85.7%   
Net profit margin %20.64.5 454.3%  
BALANCE SHEET DATA
Current assets Rs m27,1673,209 846.5%   
Current liabilities Rs m8,9172,070 430.9%   
Net working cap to sales %87.720.0 439.3%  
Current ratio x3.01.6 196.5%  
Inventory Days Days6872 93.7%  
Debtors Days Days3035 86.2%  
Net fixed assets Rs m8,862790 1,121.3%   
Share capital Rs m45850 915.0%   
"Free" reserves Rs m29,6562,419 1,225.8%   
Net worth Rs m30,1132,469 1,219.5%   
Long term debt Rs m250-   
Total assets Rs m39,4004,605 855.5%  
Interest coverage x91.5NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.51.2 42.6%   
Return on assets %11.15.6 196.8%  
Return on equity %14.210.5 135.8%  
Return on capital %22.117.7 124.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m428300 143.0%   
Fx outflow Rs m7862,015 39.0%   
Net fx Rs m-358-1,715 20.9%   
CASH FLOW
From Operations Rs m97888 1,112.7%  
From Investments Rs m351-94 -375.2%  
From Financial Activity Rs m-1,099NA-  
Net Cashflow Rs m231-6 -4,049.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 0.3 2,500.0%  
FIIs % 4.9 15.7 31.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 9.1 260.4%  
Shareholders   85,207 12,856 662.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   TORRENT PHARMA  ALKEM LABORATORIES  ELDER PHARMA  PIRAMAL ENTERPRISES  ALEMBIC PHARMA  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)

Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Mar 8, 2021 03:32 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS